Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

J. B. S. Haldane, as I knew him.

Mitchison NA.

J Genet. 2017 Nov;96(5):729. No abstract available.

2.

The discovery of T cell-B cell cooperation.

Mitchison NA.

Front Immunol. 2014 Oct 24;5:377. doi: 10.3389/fimmu.2014.00377. eCollection 2014. No abstract available.

3.

The low frequency of recessive disease: insights from ENU mutagenesis, severity of disease phenotype, GWAS associations, and demography: an analytical review.

Erickson RP, Mitchison NA.

J Appl Genet. 2014 Aug;55(3):319-27. doi: 10.1007/s13353-014-0203-3. Epub 2014 Mar 21. Review.

PMID:
24652618
4.

The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer?

Escamilla-Tilch M, Filio-Rodríguez G, García-Rocha R, Mancilla-Herrera I, Mitchison NA, Ruiz-Pacheco JA, Sánchez-García FJ, Sandoval-Borrego D, Vázquez-Sánchez EA.

Immunol Cell Biol. 2013 Nov-Dec;91(10):601-10. doi: 10.1038/icb.2013.58. Epub 2013 Oct 8. Review.

PMID:
24100386
5.

Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation.

Gimsa U, Mitchison NA, Brunner-Weinzierl MC.

Mediators Inflamm. 2013;2013:320519. doi: 10.1155/2013/320519. Epub 2013 Aug 20. Review.

8.

Human congenital diseases with mixed modes of inheritance have a shortage of recessive disease. A demographic scenario?

Mitchison NA, Bhattacharya S, Tuddenham EG.

Ann Hum Genet. 2011 Nov;75(6):688-93. doi: 10.1111/j.1469-1809.2011.00679.x. Epub 2011 Sep 22.

9.

Epistasis: the key to understanding immunological disease?

Mitchison NA, Rose AM.

Eur J Immunol. 2011 Aug;41(8):2152-4. doi: 10.1002/eji.201141811.

10.

Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.

Alpizar YA, Chain B, Collins MK, Greenwood J, Katz D, Stauss HJ, Mitchison NA.

Cancer Immunol Immunother. 2011 Aug;60(8):1127-35. doi: 10.1007/s00262-011-0985-7. Epub 2011 Apr 9. Review.

PMID:
21479639
11.

Testing the theory of immune selection in cancers that break the rules of transplantation.

Fassati A, Mitchison NA.

Cancer Immunol Immunother. 2010 May;59(5):643-51. doi: 10.1007/s00262-009-0809-1. Epub 2009 Dec 22. Review.

12.

Inflammation at the interface of innate and acquired immunity.

Lukic ML, Arsenijevic N, Mitchison NA.

Mol Immunol. 2009 Nov;47(1):1-2. doi: 10.1016/j.molimm.2009.02.012. Epub 2009 Jul 25.

PMID:
19632723
13.

Aqueous humor alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejection.

Flynn TH, Mitchison NA, Ono SJ, Larkin DF.

Am J Transplant. 2008 Jul;8(7):1537-43. doi: 10.1111/j.1600-6143.2008.02285.x.

14.

From ENU mutagenesis to population genetics.

Mitchison NA, Clarke B.

Mamm Genome. 2008 Apr;19(4):221-5. doi: 10.1007/s00335-008-9104-2. Epub 2008 Mar 26. No abstract available.

PMID:
18365275
15.

Reflections on the clonal-selection theory.

Cohn M, Mitchison NA, Paul WE, Silverstein AM, Talmage DW, Weigert M.

Nat Rev Immunol. 2007 Oct;7(10):823-30. Review.

PMID:
17893695
16.

A survey of H2 gene sequences, including new wild-derived genes.

Mitchison NA, Mayer W.

Int J Immunogenet. 2007 Feb;34(1):3-12.

PMID:
17284221
17.

Crystal-ball gazing--the future of immunological research viewed from the cutting edge.

Brent L, Cohen IR, Doherty PC, Feldmann M, Matzinger P, Ghost Lab, Holgate ST, Lachmann P, Mitchison NA, Nossal G, Rose NR, Zinkernagel R.

Clin Exp Immunol. 2007 Jan;147(1):1-10. No abstract available.

18.

The role of HLA promoters in autoimmunity.

Müller-Hilke B, Mitchison NA.

Curr Pharm Des. 2006;12(29):3743-52. Review.

PMID:
17073673
19.

Can unresolved infection precipitate autoimmune disease?

Marks DJ, Mitchison NA, Segal AW, Sieper J.

Curr Top Microbiol Immunol. 2006;305:105-25. Review.

PMID:
16724803
20.

Fundamental immunology and what it can teach us about HIV vaccine development.

Mitchison NA, Sattentau Q.

Curr Drug Targets Infect Disord. 2005 Jun;5(2):87-93. Review.

PMID:
15975015
21.

Does the polymorphism of MHC class II promoters matter?

Mitchison NA, Ono SJ, Stephens HA.

Cell Immunol. 2005 Feb;233(2):162-5. Review.

PMID:
15953596
22.
23.

T-cell-B-cell cooperation.

Mitchison NA.

Nat Rev Immunol. 2004 Apr;4(4):308-12. Review. No abstract available.

PMID:
15057789
24.

How DCs control cross-regulation between lymphocytes.

Creusot RJ, Mitchison NA.

Trends Immunol. 2004 Mar;25(3):126-31. Review. No abstract available.

PMID:
15036039
25.

George Davis Snell.

Mitchison NA.

Biogr Mem Natl Acad Sci. 2003;83:252-68. No abstract available.

PMID:
14983826
26.

T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination.

McVernon J, Mitchison NA, Moxon ER.

Lancet Infect Dis. 2004 Jan;4(1):40-3. Review.

PMID:
14720567
27.

Instruction of naive CD4+ T cells by polarized CD4+ T cells within dendritic cell clusters.

Creusot RJ, Biswas JS, Thomsen LL, Tite JP, Mitchison NA, Chain BM.

Eur J Immunol. 2003 Jun;33(6):1686-96.

28.

Patterned variation in murine MHC promoters.

Mitchison NA, Roes J.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10561-6. Epub 2002 Jul 19.

29.

The immunological synapse.

Creusot RJ, Mitchison NA, Terazzini NM.

Mol Immunol. 2002 May;38(12-13):997-1002. Review.

PMID:
12009579
30.
31.

IL-6 polymorphism, anti-IL-6 therapy and animal models of multiple myeloma.

Jeffery R, Mitchison NA.

Cytokine. 2001 Nov 7;16(3):87. No abstract available.

PMID:
11741346
32.

Tolerance and autoimmunity.

Kamradt T, Mitchison NA.

N Engl J Med. 2001 Mar 1;344(9):655-64. Review. No abstract available.

PMID:
11228281
33.

Polymorphism in regulatory gene sequences.

Mitchison NA.

Genome Biol. 2001;2(1):COMMENT2001. Epub 2000 Dec 20.

34.

Relapsing arthritis induced by cell transfer from collagen-immunised mice.

Hesse M, Mitchison NA.

Autoimmunity. 2000;32(1):27-32.

PMID:
10958172
35.

B cells in autoimmunity.

Mitchison NA, Wedderburn LR.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8750-1. No abstract available.

36.

Self/nonself discrimination among immunoregulatory (CD4) T cells.

Mitchison NA, Katz DR, Chain B.

Semin Immunol. 2000 Jun;12(3):179-83; discussion 257-344.

PMID:
10910737
37.

Interaction within clusters of dendritic cells and helper T cells during initial Th1/Th2 commitment.

Schuhbauer DM, Mitchison NA, Mueller B.

Eur J Immunol. 2000 May;30(5):1255-62.

38.
39.

Natural and induced regulation of Th1/Th2 balance.

Mitchison NA, Schuhbauer D, Müller B.

Springer Semin Immunopathol. 1999;21(3):199-210. Review.

PMID:
10666769
40.

Modulating the Th1/Th2 balance in inflammatory arthritis.

Müller B, Gimsa U, Mitchison NA, Radbruch A, Sieper J, Yin Z.

Springer Semin Immunopathol. 1998;20(1-2):181-96. Review.

PMID:
9836376
41.

Immunological tolerance. Introduction.

Mitchison NA.

Novartis Found Symp. 1998;215:1-4. No abstract available.

PMID:
9760567
43.

The distribution of variation in regulatory gene segments, as present in MHC class II promoters.

Cowell LG, Kepler TB, Janitz M, Lauster R, Mitchison NA.

Genome Res. 1998 Feb;8(2):124-34.

44.
45.

Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift.

Hauschild A, Kroeger H, Mitchison NA, Ugrinovic S, Zwingenberger K.

Clin Exp Immunol. 1997 Jun;108(3):428-31.

46.

Type II collagen serology: a guide to clinical responsiveness to oral tolerance?

Gimsa U, Sieper J, Braun J, Mitchison NA.

Rheumatol Int. 1997;16(6):237-40.

PMID:
9106934
47.

Functional significance of polymorphism among MHC class II gene promoters.

Guardiola J, Maffei A, Lauster R, Mitchison NA, Accolla RS, Sartoris S.

Tissue Antigens. 1996 Dec;48(6):615-25. Review.

PMID:
9008303
49.

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial.

Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA.

Arthritis Rheum. 1996 Jan;39(1):41-51.

PMID:
8546737

Supplemental Content

Loading ...
Support Center